Puma Biotechnology
PBYI
PBYI
82 hedge funds and large institutions have $65.5M invested in Puma Biotechnology in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 29 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $75.2M → $65.5M (-$9.72M)
31% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 29
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Holders
82
Holding in Top 10
1
Calls
$1.07M
Puts
$134K
Top Buyers
| 1 | +$1.36M | |
| 2 | +$432K | |
| 3 | +$359K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$170K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$170K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$999K | |
| 3 | -$420K | |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$281K |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$263K |